• Explore /
  • Poster
  • / A Phase Ib, Open-Label, Multi-Center Study to Assess the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of AZD1775 Monotherapy in Patients with Advanced Solid Tumors: Expansion Cohorts.

A Phase Ib, Open-Label, Multi-Center Study to Assess the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of AZD1775 Monotherapy in Patients with Advanced Solid Tumors: Expansion Cohorts.

Abstract Poster

Authors

null

Todd Michael Bauer

Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN

Todd Michael Bauer , Suzanne Fields Jones , Carol Greenlees , Carl Cook , Philip John Jewsbury , Ganesh Mugundu , Tim French , Andrew J Pierce , Mark J. O'Connor , Naomi Laing , J Carl Barrett , Dawn Michelle Stults , Melissa Lynne Johnson , J. Thaddeus Beck , Kathleen N. Moore , Jeffrey R. Infante , Howard A. Burris III, David R. Spigel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics

Track

Developmental Therapeutics and Translational Research

Sub Track

Small Molecules

Clinical Trial Registration Number

NCT02482311

Citation

J Clin Oncol 34, 2016 (suppl; abstr TPS2608)

DOI

10.1200/JCO.2016.34.15_suppl.TPS2608

Abstract #

TPS2608

Poster Bd #

299b

Abstract Disclosures

Similar Posters

First Author: Erika Paige Hamilton

First Author: Andrae L. Vandross

First Author: Hans Gelderblom

First Author: Gary Edward Richardson